HA-VHL C162F-pRc/CMV Citations (2)
Originally described in: Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG Mol Cell Biol. 1998 Feb . 18(2):732-41. PubMed
Articles Citing HA-VHL C162F-pRc/CMV
| Articles |
|---|
| ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma. Arias-Gonzalez L, Moreno-Gimeno I, del Campo AR, Serrano-Oviedo L, Valero ML, Esparis-Ogando A, de la Cruz-Morcillo MA, Melgar-Rojas P, Garcia-Cano J, Cimas FJ, Hidalgo MJ, Prado A, Callejas-Valera JL, Nam-Cha SH, Gimenez-Bachs JM, Salinas-Sanchez AS, Pandiella A, del Peso L, Sanchez-Prieto R. Neoplasia. 2013 Jun;15(6):649-59. PubMed |
| Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation. Huang SC, Zhou A, Nguyen DT, Zhang HS, Benz EJ Jr. J Biol Chem. 2016 Dec 2;291(49):25591-25607. Epub 2016 Oct 25. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.